Search

  • HOME
  • Search
Original Articles
The Effect of Topical Cyclosporine 0.05% on Tear Osmolarity for Dry Eye Syndrome.
Hyunseung Kang, San Seong, Chul Myong Choe, Se Kyung Kim, Tae Hoon Choi
J Korean Ophthalmol Soc. 2015;56(2):174-179.   Published online February 15, 2015
PDFPDF    
Randomized Controlled Trial
Efficacy of Topical Cyclosporine in Mild Dry Eye Patients Having Refractive Surgery.
Kun Wook Kang, Hong Kyun Kim
J Korean Ophthalmol Soc. 2014;55(12):1752-1757.   Published online December 15, 2014
PDFPDF    
Original Articles
Comparison of Wettability for Ocular Prosthesis Depending on Different Kinds of Artificial Tear Eye Drops.
Se Ran Jang, Il Suk Yun, Hun Sub Lim, Koung Hoon Kook
J Korean Ophthalmol Soc. 2014;55(12):1745-1751.   Published online December 15, 2014
PDFPDF    
Objective Optical Quality Analysis in Dry Eye Syndrome.
Hye Min Jeon, Dong Jun Lee
J Korean Ophthalmol Soc. 2014;55(11):1600-1605.   Published online November 15, 2014
PDFPDF    
Clinical Usefulness of a Thermal-Massaging System for Treatment of Dry Eye with Meibomian Gland Dysfunction.
Dai Woo Kim, Young A Kwon, Sang Wroul Song, Byoung Yeop Kim, Jae Lim Chung
J Korean Ophthalmol Soc. 2013;54(9):1321-1326.   Published online September 15, 2013
PDFPDF    
Effect of Sodium Hyaluronate and Cyclosporine A on Tear Film in Dry Eye Syndrome.
In Boem Chang, Jung Hyun Park, Moo Sang Kim, Tai Jin Kim
J Korean Ophthalmol Soc. 2013;54(2):231-236.   Published online February 28, 2013
PDFPDF    
Randomized Controlled Trial
Efficacy and Safety of Topical Unpreserved 0.1% Fluorometholone Ophthalmic Solution on Dry Eye Syndrome.
Joon Ho Park, Jun Hun Lee, Young Jeung Park, Hong Kyun Kim
J Korean Ophthalmol Soc. 2013;54(2):215-223.   Published online February 28, 2013
PDFPDF    
Original Articles
Changes in Higher Order Aberration According to Tear-Film Instability Analyzed by Continuous Measurement Using Wavefront.
Si Hwan Choi, Yong Il Shin
J Korean Ophthalmol Soc. 2012;53(8):1076-1080.   Published online August 15, 2012
PDFPDF    
Research on Ocular Fatigability Induced by Multimedia and Instrument Features.
Yoon Soo Jang, Ungsoo Samuel Kim, Seung Hee Baek, Yong Ran Kim, Sang Mook Gong
J Korean Ophthalmol Soc. 2012;53(5):689-693.   Published online May 15, 2012
PDFPDF    
Prevalence and Risk Factors of Dry Eye Syndrome in the Incheon Area.
Hoon Seok Jeong, Jung Soo Lim, Dae Kyu Oh et al.
J Korean Ophthalmol Soc. 2011;52(10):1135-1141.   Published online October 15, 2011
PDFPDF    
Randomized Controlled Trial
Changes in Clinical Manifestations of Dry Eye Syndrome after Cataract Surgery and the Affecting Factors.
Young Rae Roh, Sang Mok Lee, Young Keun Han, Mee Kum Kim, Won Ryang Wee, Jin Hak Lee
J Korean Ophthalmol Soc. 2011;52(9):1030-1038.   Published online September 15, 2011
PDFPDF    
Original Articles
Risk Factors for Dry Eye in Thyroid-Associated Ophthalmopathy.
Jae Ryun Kim, Hye Bin Yim, Sung Kun Chung
J Korean Ophthalmol Soc. 2011;52(7):771-776.   Published online July 15, 2011
PDFPDF    
Effect of Topical 0.05% Cyclosporine A in Dry Eye Associated With Thyroid Ophthalmopathy.
Won Choi, Yeoung Geol Park, Jae Kap Cho, Kyung Chul Yoon
J Korean Ophthalmol Soc. 2010;51(10):1319-1326.   Published online October 15, 2010
PDFPDF    
Levels of Severity in Dry Eye Syndrome According to Delphi Panel Classification.
So Hyang Chung, Kyung Sun Na, Hyung Goo Kwon et al.
J Korean Ophthalmol Soc. 2010;51(9):1179-1183.   Published online September 15, 2010
PDFPDF    
Factors Affecting Compliance With 0.05% Cyclosporine Emulsion in Patients With Dry Eye Syndrome.
Seong Kyu Im, Kyung Chul Yoon
J Korean Ophthalmol Soc. 2010;51(7):921-926.   Published online July 15, 2010
PDFPDF    

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374



ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next